Secondary Cancers Resurface in Updated Lenalidomide Maintenance Trial Data Friday, May 06, 2011 “The Pink Sheet” BY EMILY HAYES Updated data from three major randomized controlled trials in multiple myeloma confirmed higher rates of secondary malignancies along with significantly better outcomes for patients treated